These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16567401)

  • 121. Malarial proteases: assignment of function to activity.
    Barale JC; Langsley G; Mangel WF; Braun-Breton C
    Res Immunol; 1991 Oct; 142(8):672-81. PubMed ID: 1817297
    [No Abstract]   [Full Text] [Related]  

  • 122. Opiate use in the Cath Lab.
    Shah R; Kirtane AJ; McEvoy JW
    Eur Heart J; 2018 Feb; 39(8):642-645. PubMed ID: 29401287
    [No Abstract]   [Full Text] [Related]  

  • 123. Do We Need an Eye-Shield in Our Cath-Labs?
    Kiani R
    Res Cardiovasc Med; 2015 May; 4(2):e27874. PubMed ID: 26396974
    [No Abstract]   [Full Text] [Related]  

  • 124. Commentary: Cath lab 911.
    McDonald CP; Hui DS
    JTCVS Tech; 2021 Jun; 7():159-160. PubMed ID: 34318235
    [No Abstract]   [Full Text] [Related]  

  • 125. Processing of human cathepsin D in lysosomes in vitro.
    Gieselmann V; Hasilik A; von Figura K
    J Biol Chem; 1985 Mar; 260(5):3215-20. PubMed ID: 3972822
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Cathepsin D--many functions of one aspartic protease.
    Benes P; Vetvicka V; Fusek M
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):12-28. PubMed ID: 18396408
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Novel mutation and the first prenatal screening of cathepsin D deficiency (CLN10).
    Fritchie K; Siintola E; Armao D; Lehesjoki AE; Marino T; Powell C; Tennison M; Booker JM; Koch S; Partanen S; Suzuki K; Tyynelä J; Thorne LB
    Acta Neuropathol; 2009 Feb; 117(2):201-8. PubMed ID: 18762956
    [TBL] [Abstract][Full Text] [Related]  

  • 128. LC3 and Autophagy.
    Tanida I; Ueno T; Kominami E
    Methods Mol Biol; 2008; 445():77-88. PubMed ID: 18425443
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis.
    Siintola E; Partanen S; Strömme P; Haapanen A; Haltia M; Maehlen J; Lehesjoki AE; Tyynelä J
    Brain; 2006 Jun; 129(Pt 6):1438-45. PubMed ID: 16670177
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Proteolytic activation of human procathepsin D.
    Richo G; Conner GE
    Adv Exp Med Biol; 1991; 306():289-96. PubMed ID: 1812719
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Human pathology in NCL.
    Anderson GW; Goebel HH; Simonati A
    Biochim Biophys Acta; 2013 Nov; 1832(11):1807-26. PubMed ID: 23200925
    [TBL] [Abstract][Full Text] [Related]  

  • 132. New cathepsin d inhibitors with hydroxyethylamine isosteres: preparation and characterization.
    McConnell RM; Green AW; Trana CJ; McConnell MS; Lindley JF; Sayyar K; Godwin WE; Hatfield SE
    Med Chem; 2006 Jan; 2(1):27-38. PubMed ID: 16787353
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Human cathepsin D.
    Minarowska A; Gacko M; Karwowska A; Minarowski Ł
    Folia Histochem Cytobiol; 2008; 46(1):23-38. PubMed ID: 18296260
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Progranulin Stimulates the In Vitro Maturation of Pro-Cathepsin D at Acidic pH.
    Butler VJ; Cortopassi WA; Argouarch AR; Ivry SL; Craik CS; Jacobson MP; Kao AW
    J Mol Biol; 2019 Mar; 431(5):1038-1047. PubMed ID: 30690031
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Multi-Granulin Domain Peptides Bind to Pro-Cathepsin D and Stimulate Its Enzymatic Activity More Effectively Than Progranulin in Vitro.
    Butler VJ; Cortopassi WA; Gururaj S; Wang AL; Pierce OM; Jacobson MP; Kao AW
    Biochemistry; 2019 Jun; 58(23):2670-2674. PubMed ID: 31099551
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Structures at the proteolytic processing region of cathepsin D.
    Yonezawa S; Takahashi T; Wang XJ; Wong RN; Hartsuck JA; Tang J
    J Biol Chem; 1988 Nov; 263(31):16504-11. PubMed ID: 3182800
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Cathepsin D deficiency is associated with a human neurodegenerative disorder.
    Steinfeld R; Reinhardt K; Schreiber K; Hillebrand M; Kraetzner R; Bruck W; Saftig P; Gartner J
    Am J Hum Genet; 2006 Jun; 78(6):988-98. PubMed ID: 16685649
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Early infantile neuronal ceroid lipofuscinosis (CLN10 disease) associated with a novel mutation in CTSD.
    Doccini S; Sartori S; Maeser S; Pezzini F; Rossato S; Moro F; Toldo I; Przybylski M; Santorelli FM; Simonati A
    J Neurol; 2016 May; 263(5):1029-1032. PubMed ID: 27072142
    [No Abstract]   [Full Text] [Related]  

  • 139. The Role of Cathepsin D in the Pathogenesis of Human Neurodegenerative Disorders.
    Vidoni C; Follo C; Savino M; Melone MA; Isidoro C
    Med Res Rev; 2016 Sep; 36(5):845-70. PubMed ID: 27114232
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Congenital Neuronal Ceroid Lipofuscinosis with a Novel CTSD Gene Mutation: A Rare Cause of Neonatal-Onset Neurodegenerative Disorder.
    Varvagiannis K; Hanquinet S; Billieux MH; De Luca R; Rimensberger P; Lidgren M; Guipponi M; Makrythanasis P; Blouin JL; Antonarakis SE; Steinfeld R; Kern I; Poretti A; Fluss J; Fokstuen S
    Neuropediatrics; 2018 Apr; 49(2):150-153. PubMed ID: 29284168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.